Literature DB >> 23811781

The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs.

Adam D Collier1, David J Echevarria.   

Abstract

Substance abuse is a significant public health concern both domestically and worldwide. The persistent use of substances regardless of aversive consequences forces the user to give higher priority to the drug than to normal activities and obligations. The harmful and hazardous use of psychoactive substances can lead to a dependence syndrome. In this regard, the genetic and neurobiological underpinnings of reward-seeking behavior need to be fully understood in order to develop effective pharmacotherapies and other methods of treatment. Animal models are often implemented in preclinical screening for testing the efficacy of novel treatments. Several paradigms exist that model various facets of addiction including sensitization, tolerance, withdrawal, drug seeking, extinction, and relapse. Self-administration and, most notably, conditioned place preference (CPP) are relatively simple tests that serve as indicators of the aforementioned aspects of addiction by means of behavioral quantification. CPP is a commonly used technique to evaluate the motivational effects of compounds and experiences that have been associated with a positive or negative reward, which capitalizes on the basic principles of Pavlovian conditioning. During training, the unconditioned stimulus is consistently paired with a neutral set of environmental stimuli, which obtain, during conditioning, secondary motivational properties that elicit approach behavior in the absence of the unconditioned stimulus. For over 50 years, rodents have been the primary test subjects. However, the zebrafish (Danio rerio) is gaining favor as a valuable model organism in the fields of biology, genetics, and behavioral neuroscience. This paper presents a discussion on the merits, advantages, and limitations of the zebrafish model and its utility in relation to CPP.

Entities:  

Mesh:

Year:  2013        PMID: 23811781     DOI: 10.1097/FBP.0b013e328363d14a

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  16 in total

1.  Design and development of a robotic predator as a stimulus in conditioned place aversion for the study of the effect of ethanol and citalopram in zebrafish.

Authors:  Romain J G Clément; Simone Macrì; Maurizio Porfiri
Journal:  Behav Brain Res       Date:  2019-10-12       Impact factor: 3.332

Review 2.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 3.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

4.  Maternal ethanol consumption before paternal fertilization: Stimulation of hypocretin neurogenesis and ethanol intake in zebrafish offspring.

Authors:  Adam D Collier; Soe S Min; Samantha D Campbell; Mia Y Roberts; Kaylin Camidge; Sarah F Leibowitz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-08-05       Impact factor: 5.067

Review 5.  Pharmacological analyses of learning and memory in zebrafish (Danio rerio).

Authors:  Jordan M Bailey; Anthony N Oliveri; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2015-03-17       Impact factor: 3.533

Review 6.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

Review 7.  Zebrafish models for translational neuroscience research: from tank to bedside.

Authors:  Adam Michael Stewart; Oliver Braubach; Jan Spitsbergen; Robert Gerlai; Allan V Kalueff
Journal:  Trends Neurosci       Date:  2014-04-09       Impact factor: 13.837

Review 8.  Recent advances with a novel model organism: alcohol tolerance and sensitization in zebrafish (Danio rerio).

Authors:  Steven Tran; Robert Gerlai
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-03-01       Impact factor: 5.067

Review 9.  Nonhuman animal models of substance use disorders: Translational value and utility to basic science.

Authors:  Mark A Smith
Journal:  Drug Alcohol Depend       Date:  2019-11-21       Impact factor: 4.492

10.  Increased Response to 3,4-Methylenedioxymethamphetamine (MDMA) Reward and Altered Gene Expression in Zebrafish During Short- and Long-Term Nicotine Withdrawal.

Authors:  Luisa Ponzoni; Muy-Teck Teh; Jose V Torres-Perez; Caroline H Brennan; Daniela Braida; Mariaelvina Sala
Journal:  Mol Neurobiol       Date:  2020-11-24       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.